KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabre (SABR) Cash & Equivalents (2016 - 2025)

Sabre (SABR) has 13 years of Cash & Equivalents data on record, last reported at $791.6 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 9.26% year-over-year to $791.6 million; the TTM value through Dec 2025 reached $791.6 million, up 9.26%, while the annual FY2025 figure was $791.6 million, 9.26% up from the prior year.
  • Cash & Equivalents reached $791.6 million in Q4 2025 per SABR's latest filing, up from $661.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.3 billion in Q1 2021 and bottomed at $426.1 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $806.0 million, with a median of $753.6 million recorded in 2022.
  • The widest YoY moves for Cash & Equivalents: up 89.93% in 2021, down 38.64% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $978.4 million in 2021, then fell by 18.75% to $794.9 million in 2022, then dropped by 18.45% to $648.2 million in 2023, then rose by 11.77% to $724.5 million in 2024, then grew by 9.26% to $791.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $791.6 million in Q4 2025, $661.7 million in Q3 2025, and $426.1 million in Q2 2025.